Scienture Holdings, Inc.

COMMACK, NY · Biotech · Public

Tailored therapeutic formulations and delivery systems for disease treatment

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · scienture.com

Sector: Biotech
Headquarters: COMMACK, NY
Latest Form D: $1.3M, Aug 2025
Total capital: $73.8M

Federal grants: None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised: $73.8M; 12 Form D · last Aug 2025; 15 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

Latest events

Aug 2025Private capital raisedForm D · SEC · 12th filing$1.3M
Dec 2024Private capital raisedForm D · SEC · 11th filing$3.3M
Aug 2019Private capital raisedForm D · SEC · 10th filing$1M
Nov 2018Private capital raisedForm D · SEC · 9th filing$500K
Oct 2018Private capital raisedForm D · SEC · 8th filing$300K
Jul 2018Private capital raisedForm D · SEC · 7th filing$300K
Mar 2017Private capital raisedForm D · SEC · 6th filing$251K
Jan 2017Offering registeredForm D · SEC · 5th filing$15K
Nov 2015Private capital raisedForm D · SEC · 4th filing$452K
Oct 2014Private capital raisedForm D · SEC · 3rd filing$1.1M
Aug 2014Private capital raisedForm D · SEC · 2nd filing$375K
Aug 2014Private capital raisedForm D · SEC · 1st filing$64.9M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings

Donald FellDirectorNamed in SEC Form D filings
Mayur G. DoshiDirectorNamed in SEC Form D filings
Narasimhan ManiExecutive Officer, DirectorNamed in SEC Form D filings
Prashant PatelExecutive Officer, DirectorNamed in SEC Form D filings
Shankar HariharanExecutive Officer, DirectorNamed in SEC Form D filings
Subbarao G. JayanthiDirectorNamed in SEC Form D filings

Show all 7 people

Surendra AjjarapuExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

AMARIN CORP PLC\UKSimilar federal contract value in Biotech · null in contracts
KIORA PHARMACEUTICALS INCSimilar federal contract value in Biotech · null in contracts
Sagimet Biosciences Inc.Similar federal contract value in Biotech · null in contracts
Aloe Therapeutics Inc.Similar federal contract value in Biotech · null in contracts
MYOGENICA INC.Similar federal contract value in Biotech · null in contracts
Oisin Biotechnologies, Inc.Similar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.